A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
Janssen Research & Development, LLC
Janssen Research & Development, LLC
M.D. Anderson Cancer Center
Wuhan University
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
University of Arkansas
Case Comprehensive Cancer Center
University of New Mexico